Atricure Inc. buy stratec
Start price
12.04.19
/
50%
€25.43
Target price
04.11.21
€66.00
Performance (%)
15.17%
End price
05.11.21
€29.29
Summary
This prediction ended on 05.11.21 with a price of €29.29. The prediction had a final performance of 15.17%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Atricure Inc. | -2.381% | -2.381% | -60.323% | -60.323% |
| iShares Core DAX® | -4,93 % | -11,98 % | -3,49 % | 44,54 % |
| iShares Nasdaq 100 | -2,63 % | -2,22 % | 13,78 % | 80,99 % |
| iShares Nikkei 225® | -4,73 % | -10,90 % | 19,71 % | 45,26 % |
| iShares S&P 500 | -2,54 % | -3,54 % | 8,88 % | 61,12 % |
Comments by stratec for this prediction
In the thread Atricure Inc. diskutieren
stratec stimmt dem Sentiment von 'Sell' nicht zu
The stock got an Overweight rating with a $37 price target at JP Morgan. Morgan's analyst list three key reasons he likes the shares at current trading levels.
- The valuation is attractive and the name offers durable organic mid-teens top-line growth.
- Has a favorable view on the lack of competitors.
- Sees catalysts from COVERAGE data over the coming 1-year period.
Kursziel geändert auf 46,0
Kursziel geändert auf 66,0
In the thread Trading Atricure Inc.
Die von stratec gewählte maximale Laufzeit wurde überschritten